Induction and Evolution of Metaplasia in the Stomach
胃化生的诱导和进化
基本信息
- 批准号:9278155
- 负责人:
- 金额:$ 34.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdenocarcinomaAntralAtrophicCancer EtiologyCell LineCell LineageCellsCessation of lifeCharacteristicsChief CellChronicDevelopmentDysplasiaEarly DiagnosisEarly treatmentEventEvolutionFundingGastric Parietal CellsGene ExpressionGenerationsGenesGerbilsGlandGoblet CellsHelicobacterHelicobacter pyloriHumanImmigrantImmuneInflammationInflammatory InfiltrateIntestinal Intraepithelial NeoplasiaIntestinal MetaplasiaIntestinesInvestigationKRAS2 geneLeadLesionMalignant NeoplasmsMediator of activation proteinMetaplasiaMetaplasticModelingMucous body substanceMusNeckNeoplasmsNeoplastic ProcessesPathway interactionsPatientsPhenotypePopulationPremalignantProcessRiskRodent ModelRoleSmooth PursuitSouth AmericaStem cellsStomachWorkcancer typegastric fundusimprovedinducible gene expressioninsightmacrophagemalignant stomach neoplasmmouse modelneoplasticnovelnovel strategiespromoterpublic health relevancescreeningspasmolytic polypeptidetherapy developmenttransdifferentiation
项目摘要
DESCRIPTION (provided by applicant): Adenocarcinoma in the human stomach evolves in the setting of Helicobacter pylori- induced oxyntic atrophy and chronic mucous cell metaplasia. Our recent lineage mapping studies have demonstrated that metaplasia in the gastric fundus in mice does not arise from the professional progenitor cells located in the upper neck region of the glands, but rather develops from transdifferentiation of mature chief cells into Spasmolytic Polypeptide Expressing Metaplasia, or SPEM. These studies have led to a significant paradigm shift in the concepts for the origin of gastric neoplasia, suggesting that pre-neoplastic lineages do not arise from professional resident mucosal progenitor cell populations, but rather develop from transdifferentiation of mature zymogenic cell lineages. Furthermore, multiple studies now indicate that SPEM, under the influence of inflammation, can develop both increased proliferation and increasing levels of intestinalizing gene expression, and in humans gives rise to goblet cell intestinal metaplasia. Our recent investigations have demonstrated that macrophages are responsible for the promotion of proliferative SPEM progression, but the precise mediators that are responsible for the progression of SPEM towards intestinalization and dysplasia remain unknown. We therefore hypothesize that discrete intrinsic mucosal and macrophage-derived factors regulate not only the evolution, but also the progression of SPEM to more proliferative, preneoplastic metaplasia. To address this hypothesis, we will pursue two specific aims: First, we will examine the role of macrophages in the evolution and progression of metaplasia. Second, we will evaluate the role of Ras activation in evolution of SPEM from transdifferentiating chief cells and the further intestinalization of SPEM lineages in a novel model of metaplasia driven by inducible expression of activated K-Ras in chief cells. While our previous investigations have focused on the establishment of a novel pathway for generation of metaplasia through transdifferentiation of chief cells, the present investigations now focus on the
mechanisms that might drive metaplasias to preneoplasia.
描述(由申请人提供):人类胃腺癌在幽门螺杆菌诱导的氧合性萎缩和慢性粘膜细胞化生的环境中发展。我们最近的谱系图谱研究表明,小鼠胃底的化生不是由位于腺体上颈部的专业祖细胞产生的,而是由成熟的主细胞转分化发展为Spasmolytic Polypeptide expressed metaplasia (SPEM)。这些研究导致了胃肿瘤起源概念的重大范式转变,表明肿瘤前谱系不是来自专业的常驻粘膜祖细胞群,而是来自成熟的酶原细胞谱系的转分化。此外,多项研究表明,在炎症的影响下,SPEM可以增加增殖和增加肠化基因表达水平,并在人类中引起杯状细胞肠化生。我们最近的研究表明,巨噬细胞负责促进增殖性SPEM的进展,但负责SPEM向肠化和不典型增生进展的确切介质尚不清楚。因此,我们假设,离散的内在粘膜和巨噬细胞衍生的因子不仅调节了SPEM的进化,而且还调节了SPEM向增殖性更强的肿瘤前化生的进展。为了解决这一假设,我们将追求两个具体目标:首先,我们将研究巨噬细胞在化生的进化和进展中的作用。其次,我们将在一个由活化的K-Ras在主细胞中诱导表达驱动的新型化生模型中,评估Ras激活在主细胞转分化SPEM进化中的作用,以及SPEM谱系的进一步肠化。虽然我们之前的研究主要集中在通过主细胞的转分化建立一种新的化生途径,但目前的研究现在集中在这一途径上
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES Richard GOLDENRING其他文献
JAMES Richard GOLDENRING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES Richard GOLDENRING', 18)}}的其他基金
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
先天性腹泻和肠病 (PediCODE) 联盟和 BioRepository
- 批准号:
10013219 - 财政年份:2019
- 资助金额:
$ 34.33万 - 项目类别:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
先天性腹泻和肠病 (PediCODE) 联盟和 BioRepository
- 批准号:
10200797 - 财政年份:2019
- 资助金额:
$ 34.33万 - 项目类别:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
先天性腹泻和肠病 (PediCODE) 联盟和 BioRepository
- 批准号:
9815928 - 财政年份:2019
- 资助金额:
$ 34.33万 - 项目类别:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
先天性腹泻和肠病 (PediCODE) 联盟和 BioRepository
- 批准号:
10683735 - 财政年份:2019
- 资助金额:
$ 34.33万 - 项目类别:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
先天性腹泻和肠病 (PediCODE) 联盟和 BioRepository
- 批准号:
10472774 - 财政年份:2019
- 资助金额:
$ 34.33万 - 项目类别:
Generating a Porcine Model for Human Microvillus Inclusion Disease (MVID) by Gene Editing
通过基因编辑生成人类微绒毛包涵体病 (MVID) 猪模型
- 批准号:
9141460 - 财政年份:2016
- 资助金额:
$ 34.33万 - 项目类别:
Arcturus XT-TI Laser Capture Microdissection Instrument
Arcturus XT-TI 激光捕获显微切割仪器
- 批准号:
8948705 - 财政年份:2015
- 资助金额:
$ 34.33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.33万 - 项目类别:
Research Grant














{{item.name}}会员




